Tags: Drug.

Naptumomab estafenatox (ABR-217620) is a drug being developed for the treatment of various types of cancer like non-small cell lung carcinoma and renal cell carcinoma.

Fab-superantigen-fusion_protein.svg
ATC prefix
none
CAS number
676258-98-3
FDA UNII code
93T929W6LC

Loading...

This page contains content from the copyrighted Wikipedia article "Naptumomab estafenatox"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.